SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-035908
Filing Date
2023-02-13
Accepted
2023-02-13 16:31:07
Documents
12
Period of Report
2023-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d449379d8k.htm   iXBRL 8-K 24802
  Complete submission text file 0001193125-23-035908.txt   146216

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20230208.xsd EX-101.SCH 2835
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20230208_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20230208_pre.xml EX-101.PRE 11252
6 EXTRACTED XBRL INSTANCE DOCUMENT d449379d8k_htm.xml XML 3346
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 23619000
SIC: 2836 Biological Products, (No Diagnostic Substances)